Rachel Grisham, MD
Section Head Ovarian Cancer
Director, Gynecologic Medical Oncology
Memorial Sloan Kettering Cancer Center
USA

Dr. Rachel Grisham is an Associate Attending within the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSKCC) and Associate Professor of Medicine at Weill Cornell Medical College.  She is the Section Head of Ovarian Cancer Treatment and the Director of Gynecologic Medical Oncology at MSKCC Westchester. She is board certified in Medical Oncology and received her Medical Degree at Duke University School of Medicine. Dr. Grisham performed her Internal Medicine Internship and Residency at Massachusetts General Hospital.  She then came to Memorial Sloan Kettering Cancer Center where she served as the Chief Fellow of the Hematology and Oncology Fellowship Program. Dr. Grisham subsequently joined the Gynecologic Medical Oncology Service in 2012. Dr. Grisham’s research focuses on determining the molecular drivers of low-grade serous ovarian cancer and the development of targeted treatment strategies for patients with recurrent ovarian cancer. She has served as the principal investigator for over 25 clinical trials and serves on multiple committees within ASCO, NRG and SGO. She is a graduate of the ASCO leadership development program, and has served on the GOG Partners Investigators Council, NRG Rare Tumor Committee, NCCN Ovarian Cancer Guidelines Committee, and the ASCO Annual Meeting Scientific Program Committee. Dr. Grisham is the recipient of an ASCO Merit Award, a Conquer Cancer Career Development Award, an Ovarian Cancer Research Fund Liz Tilberis Award, Kaleidoscope of Hope Grants, multiple Cycle for Survival Grants, and a Translational and Integrative Medicine Research Fund Grant.